Advertisement

Advertisement

22nd ASBrS Annual Meeting

Breast Cancer

De-escalating Surgery for Women With Breast Cancer

From routine axillary lymph node dissection to sentinel lymph node surgery, the use of axillary surgery continues to evolve in breast cancer. Recently, surgical oncologists have begun to consider avoi...

Breast Cancer

Cryoablation in Low-Risk Breast Cancers: Minimally Invasive Procedure With Minimal Risk

Cryoablation is emerging as a new alternative to surgical excision for smaller early-stage, low-risk breast cancers in appropriately selected patient populations, according to data presented during th...

Breast Cancer

New Approaches Needed for Patients With Locoregional Breast Cancer Progression During Neoadjuvant Systemic Therapy

Patients with breast cancer who experience disease progression on neoadjuvant systemic therapy tend to have poor survival outcomes, even after surgical management, according to a study presented durin...

Breast Cancer
Legislation
Health-Care Policy

Breast Reconstruction Disparities Improved With Medicaid Expansion

Medicaid expansion under the Affordable Care Act was associated with significant increases in breast reconstruction among non-Hispanic Black women, achieving parity at times with non-Hispanic White wo...

Breast Cancer
Survivorship

Low-Risk Breast Cancer Survivors May Experience Long-Term Physical and Psychological Effects

Survivors of low-risk breast cancer may experience wide-ranging and significant physical and psychological symptoms after cancer treatment, according to a new study presented by Jessica Schumacher, Ph...

Breast Cancer

Cryoablation Emerging as Effective Treatment for Low-Risk Breast Cancers

Nonsurgical breast cancer cryoablation, which destroys tumor cells by exposing them to subfreezing temperatures, is proving to be an effective alternative to surgery for small breast tumors with low-r...

Breast Cancer
COVID-19

COVID-19 Pandemic Drove Strategic New Breast Cancer Approaches to Avoid Hospitalization

The COVID-19 pandemic rapidly altered breast cancer treatment approaches, with a significant rise in neoadjuvant endocrine therapy for estrogen receptor–positive tumors, enabling immediate evidence-ba...

Advertisement

Advertisement



Advertisement